Alike but Different: RAF Paralogs and Their Signaling Outputs
Open Access
- 1 May 2015
- journal article
- review article
- Published by Elsevier BV in Cell
- Vol. 161 (5), 967-970
- https://doi.org/10.1016/j.cell.2015.04.045
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant MelanomaCancer Cell, 2014
- Structure of the BRAF-MEK Complex Reveals a Kinase Activity Independent Role for BRAF in MAPK SignalingCancer Cell, 2014
- Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyondNature Reviews Cancer, 2014
- “RAF” neighborhood: Protein–protein interaction in the Raf/Mek/Erk pathwayFEBS Letters, 2014
- Oncogenic KRAS signalling in pancreatic cancerBritish Journal of Cancer, 2014
- Oncogenic and sorafenib-sensitive ARAF mutations in lung adenocarcinomaJCI Insight, 2014
- Skin Tumorigenesis Stimulated by Raf Inhibitors Relies Upon Raf Functions That Are Dependent and Independent of ERKCancer Research, 2013
- c-Raf, but Not B-Raf, Is Essential for Development of K-Ras Oncogene-Driven Non-Small Cell Lung CarcinomaCancer Cell, 2011
- Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAFCell, 2010
- Raf-1 Addiction in Ras-Induced Skin CarcinogenesisCancer Cell, 2009